Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tianyin Pharma Given SFDA OK to Launch Constipation Drug

publication date: Dec 22, 2008

Tianyin Pharmaceutical received a production license for Tongbianling Capsules, a generic TCM treatment for constipation, in a dosage of 0.25 gram/capsule. The company plans to launch the new product in February 2009. Tianyin Pharma said constipation is a common problem among China’s elderly population: about 45 million Chinese use laxatives regularly. Tianyin, which operates on a June 30 fiscal year, also reiterated its fiscal year 2009 guidance. More details...

Stock Symbol: (NYSE Alternext: TPI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital